Myomo Inc share price logo

Myomo Inc Share Price

NYSE: MYO

Small Cap

$0.81

-0.09

(-10.37%)

as on

Myomo Inc Stock Performance

as on April 22, 2026 at 6:59 am IST

  • Day's Low

    Day's High

    $0.80
    $0.95
    downward going graph

    1.23%

    Downside

    17.28%

    Upside

    downward going graph

  • 52 Week's Low

    52 Week's High

    $0.61
    $4.99
    downward going graph

    25.31%

    Downside

    515.84%

    Upside

    downward going graph

Myomo Inc share price movements today

Previous Close
$0.90
Open
$0.91
Volume
1.1M
Day's Low - High
$0.80 - $0.95
52 Week Low - High
$0.61 - $4.99

Myomo Inc Historical Returns

1 Month Return
+ 13.67 %
3 Month Return
-16 %
1 Year Return
-82.04 %
3 Year Return
+ 20.2 %
5 Year Return
-92.24 %

Myomo Inc Stock Fundamentals & Key Indicators

Check Myomo Inc market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$34.6M

EPS (TTM)

-0.3375

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

0

PEG Ratio

0

EBITDA

-13.5M

Revenue (TTM)

40.9M

Profit Margin

-38.05%

Return On Equity TTM

-86.24%

Myomo Inc vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Myomo Inc with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %
Myomo Inc image
Myomo Inc
BUY$34.6M-92.24%NA-38.05%
Boston Scientific Corp image
Boston Scientific Corp
BUY$88.5B39.82%31.4914.44%
Stryker Corporation image
Stryker Corporation
BUY$125.4B23.9%40.3112.92%
Medtronic PLC image
Medtronic PLC
BUY$105.3B-36.85%23.7713.00%
Edwards Lifesciences Corp image
Edwards Lifesciences Corp
BUY$46.3B-17.1%45.0317.69%
See all

Stock Returns calculator for Myomo Inc Stock including INR - Dollar returns

The Myomo Inc stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

Myomo Inc investment value today

Current value as on today

₹19,803

Returns

-₹80,197

(-80.2%)

Returns from Myomo Inc Stock

-₹81,960 (-81.96%)

Dollar Impact

₹1,763 (+1.76%)

Analyst Recommendation on Myomo Inc Stock

Based on 9 analysts

BUY

88.89%

Buy

11.11%

Hold

0.00%

Sell

Based on 9 analysts, 88.89% of analysts recommend a 'BUY' rating for Myomo Inc. Average target price of $4.32

Myomo Inc Share Price Target

Get share price movements and forecasts by analysts on Myomo Inc.

What analysts predicted

81.25%UPSIDE

Target Price

$4.32

Current Price

$0.81

Analyzed by

9 Analysts

Target

$4.32

Myomo Inc target price $4.32, a slight upside of 81.25% compared to current price of $0.81. According to 9 analysts rating.

Myomo Inc Stock’s Investor Sentiment and Interest

Search interest for Myomo Inc Stock has decreased by -20% in the last 30 days, reflecting a downward trend in search activity.

Time period: to

Change:-20% versus previous 30 day period

Myomo Inc Quarterly Profit & Loss

All numbers in Millions USD

Sep 2023
Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Total Revenue
5
4
3
7
9
12
9
9
10
11
Gross Profit
3
3
2
5
6
8
6
6
6
7
Operating Income
-2
-2
-3
-1
0
0
-3
-4
-3
-2
EBITDA
-1
-2
-3
-1
0
0
-3
-4
-3
-2
Interest Expense
-
0
-
-
-
-
-
-
0
0
Depreciation
0
0
0
0
0
0
0
0
0
0
Income Before Tax
-1
-2
-3
-1
0
0
-3
-4
-3
-3
Income Tax Expense
0
0
0
0
0
0
0
0
0
0
Net Income
-2
-2
-3
-1
0
0
-3
-4
-3
-3
Net Profit Margin
-39.95%
-51.72%
-102.16%
-14.91%
-10.50%
-2.16%
-35.24%
-47.99%
-36.30%
-33.59%

Myomo Inc Annual Profit & Loss

All numbers in Millions USD

Dec 2016
Dec 2017
Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Total Revenue
1
1
2
3
7
13
15
19
32
40
Gross Profit
0
1
1
2
4
10
10
13
23
26
Operating Income
-3
-6
-10
-10
-10
-10
-10
-8
-6
-14
EBITDA
-3
-6
-10
-10
-10
-9
-10
-7
-5
-12
Interest Expense
0
0
0
0
0
0
0
-
-
0
Depreciation
-
0
0
0
0
0
0
0
0
1
Income Before Tax
-3
-12
-10
-10
-11
-10
-10
-7
-5
-15
Income Tax Expense
0
5
0
0
0
0
0
0
0
0
Net Income
-3
-12
-10
-10
-11
-10
-10
-8
-6
-15
Net Profit Margin
-327.84%
-776.04%
-422.11%
-279.15%
-152.49%
-74.86%
-68.92%
-42.34%
-19.00%
-38.05%

Myomo Inc Quarterly Cash Flow

All numbers in Millions USD

Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Net Income
-2
-3
-1
0
0
-3
-4
-3
-3
Operating Cash Flow
-2
-3
-1
-1
3
-2
-8
-1
-1
Investing Cash Flow
2
-3
2
2
-1
-1
0
0
-4
Financing Cash Flow
0
5
-
0
15
0
4
0
7
Change in Cash
0
-1
0
1
17
-4
-5
-1
1

Myomo Inc Annual Cash Flow

All numbers in Millions USD

Dec 2017
Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Net Income
-12
-10
-10
-11
-10
-10
-8
-6
-15
Operating Cash Flow
-6
-9
-10
-9
-9
-10
-6
-3
-14
Investing Cash Flow
0
0
0
0
0
0
-2
0
-7
Financing Cash Flow
18
3
8
16
13
0
9
20
11
Change in Cash
12
-6
-2
7
3
-10
1
17
-10

Myomo Inc News & Key Events

  • img

    Today's Timeline - 09 March

    Tue, 01:35 AM

    -

    Myomo enters network participation agreements with Elevance Health, expanding access to MyoPro® for over 80 million covered lives.

Insights on Myomo Inc

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    Revenue Rich

    img

    Revenue is up for the last 3 quarters, 9.65M → 11.35M (in $), with an average increase of 7.7% per quarter

  • imgPOSITIVE IMPACT

    Best in 3 Years

    img

    In the last 3 years, MYO has outperformed top 5 stocks with highest market-cap in its industry

  • imgNO EFFECT

    Against Peers

    img

    In the last 1 year, Edwards Lifesciences Corp. has given 12.9% return, outperforming this stock by 94.9%

  • imgNEGATIVE IMPACT

    Price Dip

    img

    In the last 1 year, MYO stock has moved down by -82.0%

  • imgNEGATIVE IMPACT

    Profit Down

    img

    Netprofit is down for the last 2 quarters, -3.66M → -3.81M (in $), with an average decrease of 4.1% per quarter

About Myomo Inc

Myomo, Inc., a wearable medical robotics company, designs, develops, and produces myoelectric orthotics for people with neuromuscular disorders in the United States, Germany, and internationally. The company offers MyoPro, a myoelectric-controlled upper limb brace or orthosis product used for supporting a patient's weak or paralyzed arm to enable and improve functional activities of daily living. It also provides MyoPro 2 that includes control technology, configuration software and user interface, and pop-out battery for extended use of the brace; MyoPro2+, which comprises 3D printed orthotics capability, software enhancements, and a design for donning and doffing of the device; MyoGames, a virtual training platform; and MyoPro 2x Video Library. In addition, the company offers MyoCare, a post-delivery program that provides follow-up care with clients, therapists, and referral sources; MYOMO; MyoPal; and MyoCoach. Its products are designed to help adults and adolescents with neuromuscular conditions due to brachial plexus injury, stroke, traumatic brain injury, spinal cord injury, and other neurological disorders. The company sells its products through various sales channels, including orthotics and prosthetics providers, veteran's administration, and distributors. Myomo, Inc. was incorporated in 2004 and is headquartered in Burlington, Massachusetts.
OrganisationMyomo Inc
Headquarters45 Blue Sky Dr., Burlington, MA, United States, 01803
IndustryMedical Devices
CEOMr. Paul R. Gudonis
E-voting on sharesClick here to vote

Key Management of Myomo Inc

Name

Title

Ms. Kathy Sawyers

Sr. Director of Clinical Outcomes

Mr. Malcolm G. Bock

Vice President of Engineering & Product Strategy

Mr. Paul R. Gudonis

President, CEO & Chairman

Mr. David A. Henry

Chief Financial Officer

Dr. Harry Kovelman M.D.

Chief Medical Officer

Mr. Colin Anderson

Global Director of Operations

Ms. Galina Shtivelman

Senior Director of Human Resources

Mr. Micah J. Mitchell

Chief Commercial Officer

FAQs

What is Myomo Inc share price today?

Myomo Inc share price today is $0.81 as on at the close of the market. Myomo Inc share today touched a day high of $0.95 and a low of $0.8.

What is the 52 week high and 52 week low for Myomo Inc share?

Myomo Inc share touched a 52 week high of $4.99 on and a 52 week low of $0.61 on . Myomo Inc stock price today i.e. is closed at $0.81,which is 83.76% down from its 52 week high and 33.88% up from its 52 week low.

What is Myomo Inc's market capitalisation today?

Myomo Inc market capitalisation is $0.00T as on .

How to invest in Myomo Inc Stock (MYO) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Myomo Inc on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Myomo Inc Shares that will get you 1.8519 shares as per Myomo Inc share price of $0.81 per share as on April 22, 2026 at 1:29 am IST.

What is the minimum amount required to buy Myomo Inc Stock (MYO) from India?

Indian investors can start investing in Myomo Inc (MYO) shares with as little as ₹93.505 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹935.05 in Myomo Inc stock (as per the Rupee-Dollar exchange rate as on ). Based on Myomo Inc share’s latest price of $0.81 as on April 22, 2026 at 1:29 am IST, you will get 12.3457 shares of Myomo Inc. Learn more about fractional shares .

What are the returns that Myomo Inc has given to Indian investors in the last 5 years?

Myomo Inc stock has given -92.24% share price returns and 23.44% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?